Gyre Therapeutics Inc (GYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 20,948 | 0 | 6 | 1,018 | 399 |
| Cost of Goods | 9,163 | N/A | N/A | N/A | N/A |
| Gross Profit | 11,785 | N/A | 6 | 1,018 | 399 |
| Operating Expenses | 69,318 | 57,277 | 33,828 | 22,840 | 20,817 |
| Operating Income | -57,370 | -57,277 | -33,822 | -21,822 | -20,418 |
| Other Income | 1,129 | 2,099 | 3,767 | 261 | 3,473 |
| Pre-tax Income | -56,241 | -55,178 | -30,055 | -21,561 | -16,945 |
| Net Income Continuous | -56,241 | -55,178 | -30,055 | -21,561 | -16,945 |
| Net Income | $-56,241 | $-55,178 | $-30,055 | $-21,561 | $-16,945 |
| EPS Basic Total Ops | -43.93 | -68.97 | -40.18 | -111.69 | -326.09 |
| EPS Basic Continuous Ops | -43.96 | -68.92 | -40.18 | -94.41 | -326.12 |
| EPS Diluted Total Ops | -43.93 | -68.97 | -40.18 | -111.69 | -326.09 |
| EPS Diluted Continuous Ops | -43.96 | -68.92 | -40.18 | -94.41 | -326.12 |
| EPS Diluted Before Non-Recurring Items | -43.93 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-57,232 | $-57,131 | $-33,673 | $-21,649 | $-20,029 |